Work with us
YBRI has developed a long term integrated strategy for biomedical science in York, providing an optimal structure for the delivery of biomedical research excellence.
We are here to facilitate and nurture interdisciplinary research in biomedical research both in York and beyond through working with organisations and independent research fellows.
External organisations
Who can work with us?
- Pharmaceutical companies
- Biotech companies
- Businesses
- Government bodies
- UK and international universities
- Research institutes
- Charities
- Non-governmental organisations
- National Health Service (NHS)
- Private healthcare providers
How can we help?
- Provide consultancy, advice, knowledge and expertise from world-leading academic
- Facilitate contact with relevant biomedical researchers at York and within our wider network
- Conduct collaborative research on your behalf and in partnership
- Host events and workshops to create networking opportunities
- Publicise the outputs and impacts of projects
YBRI members have colleagues, collaborators and partners locally, nationally and internationally in academic institutions, hospitals and industry. If you’d like to know more, please get in touch.
Contact us
York Biomedical Research Institute
ybri@york.ac.uk
B/H/002, Department of Biology, Wentworth Way, University of York, York, YO10 5NG
Twitter
- Professor Jeremy Mottram works with the Novartis Institute of Tropical Diseases to identify novel chemical entities that may be developed into treatment for leishmaniasis (Khare, Nature 2016) and human African trypanosomiasis (Saldivia, Nature Microbiology 2020).
- Contact: jeremy.mottram@york.ac.uk
- Contact: jeremy.mottram@york.ac.uk
- Professor Jennifer Southgate and her team in the Jack Birch Unit for Molecular Carcinogenesis have a functionally-differentiated human urothelial tissue platform (bladder and ureter) available through Kystis for collaborative and contract research partnerships. Potential applications include urinary tract infections and drug toxicity.
- Contact: info@kystis.com
- Contact: info@kystis.com
- Professor Ian Hitchcock is working with Incyte to elucidate novel mechanisms in myeloproliferative neoplasm development in order to develop more targeted therapies.
- Contact: ian.hitchcock@york.ac.uk
- Contact: ian.hitchcock@york.ac.uk
- Professor Steve Johnson and Professor Thomas Krauss work with Aptamer Group to identify and characterise novel Optimer binding agents that can easily be integrated into low-cost and handheld diagnostic devices (Kenaan, Biosense. Bioelect. 2020)
- Professor Neil Hunt collaborates with UCB on the development of novel high throughput screening methods based on 2D-IR spectroscopy for use in drug design applications.
- Contact: neil.hunt@york.ac.uk
The York Biomedical Research Institute offered me a unique combination of cellular and molecular tools to underpin the development of a novel system for studying HIF biology. Collaborating with established experts in the field of haematological malignancies - Professor Ian Hitchcock and Dr David Kent - facilitated my transition from solid cancers to blood cancers, and created a research niche within which to address these fundamental biological questions.
Dr Katherine Bridge, Kay Kendall Leukaemia Fund Intermediate Research Fellow, Biology
Our research
Our research spans three main research themes:
and two cross-cutting themes:
Contact us
York Biomedical Research Institute
ybri@york.ac.uk
B/H/002, Department of Biology, Wentworth Way, University of York, York, YO10 5NG
Twitter